Pages that link to "Q28390899"

The following pages link to In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer (Q28390899):

Displaying 15 items.

• Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology (Q26799114) (← links)
• High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy (Q26853566) (← links)
• Therapeutic cancer vaccines: past, present, and future (Q26863283) (← links)
• Metabolic influences that regulate dendritic cell function in tumors (Q27011306) (← links)
• Small molecule inhibits activity of scavenger receptor A: Lead identification and preliminary studies (Q28397940) (← links)
• Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation (Q37250352) (← links)
• The future of glioblastoma therapy: synergism of standard of care and immunotherapy (Q38255481) (← links)
• Antigen-specific vaccines for cancer treatment (Q38284692) (← links)
• Engineering better immunotherapies via RNA interference (Q38284703) (← links)
• Design, synthesis, and characterization of rhein analogs as novel inhibitors of scavenger receptor A. (Q38729098) (← links)
• Understanding molecular interactions between scavenger receptor A and its natural product inhibitors through molecular modeling studies. (Q45066494) (← links)
• Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy (Q64244750) (← links)
• Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome? (Q89509390) (← links)
• Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study (Q92092797) (← links)
• Immunometabolism: A new target for improving cancer immunotherapy (Q92768544) (← links)